Biotechnology Novartis spends billions in 2025 Newsletter Signup – Under Article / In Page “*” indicates required fields The year 2024 was regarded as a reset year with lackluster deal performance in the biopharma industry. This year was predicted to witness a surge in mergers and acquisitions (M&As) deals in the sector and in the latter half of the year, the pharma giant Novartis has struck big. Novartis expanding cardiovascular research Novartis buys Tourmaline […] Written by Roohi Mariam Peter October 22, 2025October 22, 2025 Saving Bookmark this article Bookmarked
Biotechnology ESMO: AstraZeneca believes latest data 'validate' going it alone on next-gen ADCs Europe’s leading cancer conference may be swimming in ADC data, but AstraZeneca remains convinced its in-house pipeline sets the pharma apart. Written by Admin October 19, 2025October 19, 2025 Saving Bookmark this article Bookmarked
Biotechnology Tubulis secures €308m in record-breaking Series C financing Munich-based biotech Tubulis has closed a €308m (US$361m) Series C financing round – the largest of its kind for a European biotechnology company at the Series C stage and also the world’s largest financing for a private ADC (antibody–drug conjugate) developer. The round was led by Venrock Healthcare Capital Partners, joined by new investors Wellington […] Written by Georg Kääb October 16, 2025October 16, 2025 Saving Bookmark this article Bookmarked
Biotechnology Regeneron, with ‘game-changing’ new data, to seek approval of hearing loss gene therapy Study results published in The New England Journal of Medicine show the therapy significantly improved hearing in nearly a dozen children with a rare, genetic form of deafness. Written by Jacob Bell October 12, 2025October 12, 2025 Saving Bookmark this article Bookmarked
Biotechnology Unraveling Ageing-Parkinson’s Link: PD-AGE Advances In the rapidly evolving field of neurodegenerative disease research, Parkinson’s disease (PD) remains a focal point due to its complex interplay with the ageing process. A pioneering initiative led by the PD-AGE network seeks to illuminate this nexus through a groundbreaking study that emphasizes the urgent need for standardisation in in vitro models and experimental […] Written by Bioengineer October 9, 2025October 9, 2025 Saving Bookmark this article Bookmarked
Biotechnology The biggest biotech funding rounds in September 2025 Newsletter Signup – Under Article / In Page “*” indicates required fields The companies uniQure, Dianthus Therapeutics, and Mineralys Therapeutics bagged the biggest biotech funding rounds overall in September 2025 across private and public funding types. In this article, we break down last month’s private and public fundraising activity, looking at the largest rounds in […] Written by Willow Shah-Neville October 6, 2025October 6, 2025 Saving Bookmark this article Bookmarked
Biotechnology Singapore drug discovery platform heads to Nasdaq via SPAC deal An AI-driven drug discovery platform will receive a step up onto the Nasdaq via a reverse merger with a blank check company. Written by Admin October 2, 2025October 2, 2025 Saving Bookmark this article Bookmarked
Biotechnology MSD Secures Option on EVX-B3 Under the agreement, MSD will assume full responsibility and carry all costs for the further development of the EVX-B3 vaccine. The vaccine is designed to combat pathogens that cause opportunistic, recurrent infections, such as S. aureus, Enterococcus sp., and uropathogenic E. coli. So far, the companies have not disclosed further details, but the vaccine is reportedly […] Written by Thomas Gabrielczyk September 29, 2025September 29, 2025 Saving Bookmark this article Bookmarked
Biotechnology Lilly’s oral SERD gets FDA nod in advanced breast cancer The clearance of Inluriyo is another development among a group of oral medicines aiming to supplant a widely used, injectable type of hormone therapy. Written by Ben Fidler September 26, 2025September 26, 2025 Saving Bookmark this article Bookmarked
Biotechnology “‘Youth Molecule’ Shows Promise in Enhancing Quality of Life for In a groundbreaking expert consensus published in Nature Aging, a collective of over 25 internationally renowned scientists and clinicians have shed new light on the pivotal role of nicotinamide adenine dinucleotide (NAD⁺) in aging biology and metabolic health. This comprehensive review comes as the scientific community intensifies efforts to decipher how modulation of NAD⁺ metabolism […] Written by Bioengineer September 22, 2025September 22, 2025 Saving Bookmark this article Bookmarked
Strategien für das Online-Casino: Wie man die Chancen maximiert und den Hausvorteil überwindet Auto-generated excerpt Written by yam3t3 October 25, 2025October 25, 2025 Saving Bookmark this article Bookmarked
Die ultimative Spielervorstellung: Willkommen bei Gama Auto-generated excerpt Written by yam3t3 October 25, 2025October 25, 2025 Saving Bookmark this article Bookmarked
Strategien für das Online-Casino: Wie man die Chancen maximiert und den Hausvorteil überwindet Auto-generated excerpt Written by yam3t3 October 25, 2025October 25, 2025 Saving Bookmark this article Bookmarked
Die ultimative Spielervorstellung: Willkommen bei Gama Auto-generated excerpt Written by yam3t3 October 25, 2025October 25, 2025 Saving Bookmark this article Bookmarked
GigaspinZ: De Ultieme Casino-ervaring Auto-generated excerpt Written by yam3t3 October 25, 2025October 25, 2025 Saving Bookmark this article Bookmarked
Understanding PMDA Validation Rules v5.0 The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has always led the charge in ensuring the safety and efficacy of drug development. Their latest update, the PMDA Validation Rules version 5.0, which took effect on April 1, 2024, marks another significant step in this mission. Let’s break down what these new rules mean and […] Written by Admin July 10, 2024July 10, 2024 Saving Bookmark this article Bookmarked
Enhance Your SEND Submissions! Join PointCross on May 29th, 2024, at 12 PM EST / 9 AM PST for a must-attend webinar: The Most Common Issues in Preparing SEND. Ideal for professionals in data submission and regulatory compliance, this webinar offers valuable insights from our seasoned experts. Why Attend? Why PointCross? With over 10 years of experience and more […] Written by Admin May 23, 2024May 23, 2024 Saving Bookmark this article Bookmarked